MARKET

NUVB

NUVB

Nuvation Bio Inc
NYSE
5.65
-0.16
-2.75%
After Hours: 5.61 -0.04 -0.71% 19:59 06/26 EDT
OPEN
5.80
PREV CLOSE
5.81
HIGH
6.08
LOW
5.50
VOLUME
35.24M
TURNOVER
--
52 WEEK HIGH
9.75
52 WEEK LOW
1.810
MARKET CAP
1.97B
P/E (TTM)
-13.1979
1D
5D
1M
3M
1Y
5Y
1D
Nuvation Bio (NUVB) Completes $250 Million Note Offering, Is The Stock Fully Priced?
Simply Wall St · 22h ago
Nuvation Bio prices upsized offering of $250M of convertible senior notes
TipRanks · 2d ago
Nuvation Bio Prices Upsized $250 Mln Offering Of Convertible Notes; Stock Down
NASDAQ · 2d ago
Nuvation Bio prices $250M convertible notes offering
Seeking Alpha · 2d ago
*Nuvation Bio Prices Underwritten Offering of $250M of 0.75% Convertible Senior Notes Due 2032>NUVB
Dow Jones · 2d ago
*Nuvation Bio: Sale of Notes to Underwriters Expected to Close on June 30 >NUVB
Dow Jones · 2d ago
*Nuvation Bio: Aggregate Principal Amount of Offering Increased From Previously Announced Size of $200M >NUVB
Dow Jones · 2d ago
Nuvation Bio falls -10.1%
TipRanks · 3d ago
More
About NUVB
Nuvation Bio Inc. is a global oncology company. The Company is focused on tackling cancer treatment. Its diverse pipeline includes taletrectinib (IBTROZI), a next-generation ROS1 inhibitor; safusidenib, a brain-penetrant IDH1 inhibitor, and a drug-drug conjugate (DDC) program. IBTROZI is an oral, potent, central nervous system-active, selective, next-generation ROS1 inhibitor. Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1), which is detected in various tumors, including gliomas. Its platform leverages its drug discovery and chemistry expertise to find the minimum target binding sites of drug X and drug Y and fuse them together, while maintaining activity. Its DDCs are designed to selectively bind to intracellular as well as surface cell membrane targets that are expressed more highly in specific target tissues and to potently deliver anti-cancer warheads to these target tissues.

Webull offers Nuvation Bio Inc stock information, including NYSE: NUVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUVB stock methods without spending real money on the virtual paper trading platform.